They are used in clinical settings to accelerate wound healing and calm the skin
The method of any one of embodiments 1-22, wherein the composition comprises a gel or a viscous preparation
Both oral and injectable GLP-1 treatments may cause nausea, vomiting, constipation, diarrhea, abdominal discomfort, and reduced food tolerance
Consultation with a healthcare professional and, where appropriate, a specialized lawyer is strongly recommended before any action related to this peptide
At day 5 the confluent cell layers were supplemented with cARLA cocktail
Edited by Alessandro Finazzi-Agr Supplementary information Rights and permissions Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made